Kynam Capital Management, LP Nektar Therapeutics Transaction History
Kynam Capital Management, LP
- $953 Million
- Q1 2024
A detailed history of Kynam Capital Management, LP transactions in Nektar Therapeutics stock. As of the latest transaction made, Kynam Capital Management, LP holds 200,000 shares of NKTR stock, worth $258,000. This represents 0.08% of its overall portfolio holdings.
Number of Shares
200,000Holding current value
$258,000% of portfolio
0.08%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NKTR
# of Institutions
128Shares Held
111MCall Options Held
150KPut Options Held
4K-
Deep Track Capital, LP Greenwich, CT18.4MShares$23.7 Million0.57% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$15.5 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA7.57MShares$9.76 Million0.02% of portfolio
-
Primecap Management CO Pasadena, CA6.97MShares$8.99 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.88MShares$7.58 Million0.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $242M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...